Novo Nordisk Falls 7% as Post-Wegovy Growth Plan Fails to Ease Competition Fears; Eli Lilly Slips, Viking Therapeutics Edges Higher

Reported by Yahoo Finance · Published 21 Sep 2026, 9:45 PM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Oil falls on increased Gulf supply and hopes for US-Iran talks 1 hr ago Bursa opens lower as investors take profits amid US-Iran talks 1 hr ago Exclusive-GM CEO Mary Barra to attend Trump's state dinner for Xi, sources say 1 hr ago South Korea plans to cut its reliance on Middle crude oil imports to 50% by 2035 2 hr ago Ringgit opens higher against US dollar as oil prices ease 3 hr ago Trump supports diesel export ban as fuel prices hit records 3 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Novo Nordisk Falls 7% as Post-Wegovy Growth Plan Fails to Ease Competition Fears; Eli Lilly Slips, Viking Therapeutics Edges Higher

Summary

More in Markets

CFTC says prediction markets' 'mentions' contracts present a higher risk of manipulation

The Nasdaq’s rapid rise to a record is sending a message to investors: Don’t wait for a pullback to buy

Why Apple could soon join Nvidia in the exclusive $5 trillion club

Want to bet on risky, high-beta stocks? Why you should wait for this week in October.

My husband and I are in our 50s and have no kids. We have $2 million in IRAs and 401(k)s. Do we really need a will?

Jet fuel is following diesel’s price jump as the Hormuz supply shock hits the skies